This means your digestive system has to work hard to adjust, which may lead to diarrhea
A 2025 study found irregular menstrual cycles dropped from 86% to 32% on tirzepatide, with significant improvement in insulin resistance.[10] A real-world study presented at ObesityWeek 2025 found over 90% of PCOS patients on tirzepatide hit at least 10% weight loss within 10 months.[11] Theres even a registered clinical trial specifically testing tirzepatide for PCOS
Neither peptide "wins" outright because they act on different phases of the repair cascade rather than competing: for localised tendon and ligament models, BPC-157 has the stronger preclinical evidence (early-phase angiogenesis and growth-factor signalling)
DHH-B (Capsule) A powerful antioxidant that reduces oxidative stress in the brain, promoting relaxation and reducing anxiety
When examining aortic smooth muscle cells in culture, it was observed that GHRP-2 might counteract the generation of peroxides induced by OxLDL
Finally, this time allows for metabolic adaptation as your body adjusts to maintaining your new weight without medication support